Product
CAR T-cell and Cellular Therapies
1 clinical trial
2 indications
Indication
adverse drug reactionsIndication
CancerClinical trial
Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse EventsStatus: Completed, Estimated PCD: 2023-01-01